In fact, it might be advisable to consider PI3K inhibitors in the treatment of PHTS patients not only to reverse classical PHTS lesions (such as skin hamartomas) [24], but also to treat obesity [25, 26]. Here, PIK3CA is linked to obesity due to melanocortin 4 receptor deficiency.